aluates Reports

$ 0.0

Automative

Global Infectious Diseases In Vitro Diagnostics Market Research Report 2024

Published Date: February 2024

Report Code: QYRE-Auto-0B6149

Global Infectious Diseases In Vitro Diagnostics Market Size Status and Forecast 2021 2027

BUY CHAPTERS

Global Infectious Diseases In Vitro Diagnostics Market Research Report 2024

Code: QYRE-Auto-0B6149

Report

February 2024

Pages:80

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Abbott

Alere Inc

Quidel

F.Hoffmann-La Roche

Orasure Technologies

Cepheid Inc

Hologic Inc

Qiagen NV

Bio Rad Laboratories

Siemens Healthcare

Infectious Diseases In Vitro Diagnostics Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Infectious Diseases In Vitro Diagnostics Market

The global Infectious Diseases In Vitro Diagnostics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Infectious Diseases In Vitro Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Infectious Diseases In Vitro Diagnostics.

Report Scope

The Infectious Diseases In Vitro Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Infectious Diseases In Vitro Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Infectious Diseases In Vitro Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Infectious Diseases In Vitro Diagnostics Market Report

Report Metric	Details
Report Name	Infectious Diseases In Vitro Diagnostics Market
CAGR	5%
Segment by Type	MRSA Streptococcus TB and Drug-resistant TB Gastro-intestinal Panel Testing HIV Hepatitis C Others
Segment by Application	Immunochemistry Molecular Diagnostics Microbiology Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	BD, Abbott, Alere, Quidel, F. Hoffmann-La Roche, Orasure Technologies, Cepheid, Hologic, Qiagen, Bio-Rad Laboratories, Siemens Healthcare
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Infectious Diseases In Vitro Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Infectious Diseases In Vitro Diagnostics Market report?

Ans: The main players in the Infectious Diseases In Vitro Diagnostics Market are BD, Abbott, Alere, Quidel, F. Hoffmann-La Roche, Orasure Technologies, Cepheid, Hologic, Qiagen, Bio-Rad Laboratories, Siemens Healthcare

What are the Application segmentation covered in the Infectious Diseases In Vitro Diagnostics Market report?

Ans: The Applications covered in the Infectious Diseases In Vitro Diagnostics Market report are Immunochemistry, Molecular Diagnostics, Microbiology, Others

What are the Type segmentation covered in the Infectious Diseases In Vitro Diagnostics Market report?

Ans: The Types covered in the Infectious Diseases In Vitro Diagnostics Market report are MRSA, Streptococcus, TB and Drug-resistant TB, Gastro-intestinal Panel Testing, HIV, Hepatitis C, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Infectious Diseases In Vitro Diagnostics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 MRSA

1.2.3 Streptococcus

1.2.4 TB and Drug-resistant TB

1.2.5 Gastro-intestinal Panel Testing

1.2.6 HIV

1.2.7 Hepatitis C

1.2.8 Others

1.3 Market by Application

1.3.1 Global Infectious Diseases In Vitro Diagnostics Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Immunochemistry

1.3.3 Molecular Diagnostics

1.3.4 Microbiology

1.3.5 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Infectious Diseases In Vitro Diagnostics Market Perspective (2019-2030)

2.2 Infectious Diseases In Vitro Diagnostics Growth Trends by Region

2.2.1 Global Infectious Diseases In Vitro Diagnostics Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Infectious Diseases In Vitro Diagnostics Historic Market Size by Region (2019-2024)

2.2.3 Infectious Diseases In Vitro Diagnostics Forecasted Market Size by Region (2025-2030)

2.3 Infectious Diseases In Vitro Diagnostics Market Dynamics

2.3.1 Infectious Diseases In Vitro Diagnostics Industry Trends

2.3.2 Infectious Diseases In Vitro Diagnostics Market Drivers

2.3.3 Infectious Diseases In Vitro Diagnostics Market Challenges

2.3.4 Infectious Diseases In Vitro Diagnostics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Infectious Diseases In Vitro Diagnostics Players by Revenue

3.1.1 Global Top Infectious Diseases In Vitro Diagnostics Players by Revenue (2019-2024)

3.1.2 Global Infectious Diseases In Vitro Diagnostics Revenue Market Share by Players (2019-2024)

3.2 Global Infectious Diseases In Vitro Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Infectious Diseases In Vitro Diagnostics Revenue

3.4 Global Infectious Diseases In Vitro Diagnostics Market Concentration Ratio

3.4.1 Global Infectious Diseases In Vitro Diagnostics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Infectious Diseases In Vitro Diagnostics Revenue in 2023

3.5 Infectious Diseases In Vitro Diagnostics Key Players Head office and Area Served

3.6 Key Players Infectious Diseases In Vitro Diagnostics Product Solution and Service

3.7 Date of Enter into Infectious Diseases In Vitro Diagnostics Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Infectious Diseases In Vitro Diagnostics Breakdown Data by Type

4.1 Global Infectious Diseases In Vitro Diagnostics Historic Market Size by Type (2019-2024)

4.2 Global Infectious Diseases In Vitro Diagnostics Forecasted Market Size by Type (2025-2030)

5 Infectious Diseases In Vitro Diagnostics Breakdown Data by Application

5.1 Global Infectious Diseases In Vitro Diagnostics Historic Market Size by Application (2019-2024)

5.2 Global Infectious Diseases In Vitro Diagnostics Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Infectious Diseases In Vitro Diagnostics Market Size (2019-2030)

6.2 North America Infectious Diseases In Vitro Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Infectious Diseases In Vitro Diagnostics Market Size by Country (2019-2024)

6.4 North America Infectious Diseases In Vitro Diagnostics Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Infectious Diseases In Vitro Diagnostics Market Size (2019-2030)

7.2 Europe Infectious Diseases In Vitro Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Infectious Diseases In Vitro Diagnostics Market Size by Country (2019-2024)

7.4 Europe Infectious Diseases In Vitro Diagnostics Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Infectious Diseases In Vitro Diagnostics Market Size (2019-2030)

8.2 Asia-Pacific Infectious Diseases In Vitro Diagnostics Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Infectious Diseases In Vitro Diagnostics Market Size by Region (2019-2024)

8.4 Asia-Pacific Infectious Diseases In Vitro Diagnostics Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Infectious Diseases In Vitro Diagnostics Market Size (2019-2030)

9.2 Latin America Infectious Diseases In Vitro Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Infectious Diseases In Vitro Diagnostics Market Size by Country (2019-2024)

9.4 Latin America Infectious Diseases In Vitro Diagnostics Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Infectious Diseases In Vitro Diagnostics Market Size (2019-2030)

10.2 Middle East & Africa Infectious Diseases In Vitro Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Infectious Diseases In Vitro Diagnostics Market Size by Country (2019-2024)

10.4 Middle East & Africa Infectious Diseases In Vitro Diagnostics Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 BD

11.1.1 BD Company Detail

11.1.2 BD Business Overview

11.1.3 BD Infectious Diseases In Vitro Diagnostics Introduction

11.1.4 BD Revenue in Infectious Diseases In Vitro Diagnostics Business (2019-2024)

11.1.5 BD Recent Development

11.2 Abbott

11.2.1 Abbott Company Detail

11.2.2 Abbott Business Overview

11.2.3 Abbott Infectious Diseases In Vitro Diagnostics Introduction

11.2.4 Abbott Revenue in Infectious Diseases In Vitro Diagnostics Business (2019-2024)

11.2.5 Abbott Recent Development

11.3 Alere

11.3.1 Alere Company Detail

11.3.2 Alere Business Overview

11.3.3 Alere Infectious Diseases In Vitro Diagnostics Introduction

11.3.4 Alere Revenue in Infectious Diseases In Vitro Diagnostics Business (2019-2024)

11.3.5 Alere Recent Development

11.4 Quidel

11.4.1 Quidel Company Detail

11.4.2 Quidel Business Overview

11.4.3 Quidel Infectious Diseases In Vitro Diagnostics Introduction

11.4.4 Quidel Revenue in Infectious Diseases In Vitro Diagnostics Business (2019-2024)

11.4.5 Quidel Recent Development

11.5 F. Hoffmann-La Roche

11.5.1 F. Hoffmann-La Roche Company Detail

11.5.2 F. Hoffmann-La Roche Business Overview

11.5.3 F. Hoffmann-La Roche Infectious Diseases In Vitro Diagnostics Introduction

11.5.4 F. Hoffmann-La Roche Revenue in Infectious Diseases In Vitro Diagnostics Business (2019-2024)

11.5.5 F. Hoffmann-La Roche Recent Development

11.6 Orasure Technologies

11.6.1 Orasure Technologies Company Detail

11.6.2 Orasure Technologies Business Overview

11.6.3 Orasure Technologies Infectious Diseases In Vitro Diagnostics Introduction

11.6.4 Orasure Technologies Revenue in Infectious Diseases In Vitro Diagnostics Business (2019-2024)

11.6.5 Orasure Technologies Recent Development

11.7 Cepheid

11.7.1 Cepheid Company Detail

11.7.2 Cepheid Business Overview

11.7.3 Cepheid Infectious Diseases In Vitro Diagnostics Introduction

11.7.4 Cepheid Revenue in Infectious Diseases In Vitro Diagnostics Business (2019-2024)

11.7.5 Cepheid Recent Development

11.8 Hologic

11.8.1 Hologic Company Detail

11.8.2 Hologic Business Overview

11.8.3 Hologic Infectious Diseases In Vitro Diagnostics Introduction

11.8.4 Hologic Revenue in Infectious Diseases In Vitro Diagnostics Business (2019-2024)

11.8.5 Hologic Recent Development

11.9 Qiagen

11.9.1 Qiagen Company Detail

11.9.2 Qiagen Business Overview

11.9.3 Qiagen Infectious Diseases In Vitro Diagnostics Introduction

11.9.4 Qiagen Revenue in Infectious Diseases In Vitro Diagnostics Business (2019-2024)

11.9.5 Qiagen Recent Development

11.10 Bio-Rad Laboratories

11.10.1 Bio-Rad Laboratories Company Detail

11.10.2 Bio-Rad Laboratories Business Overview

11.10.3 Bio-Rad Laboratories Infectious Diseases In Vitro Diagnostics Introduction

11.10.4 Bio-Rad Laboratories Revenue in Infectious Diseases In Vitro Diagnostics Business (2019-2024)

11.10.5 Bio-Rad Laboratories Recent Development

11.11 Siemens Healthcare

11.11.1 Siemens Healthcare Company Detail

11.11.2 Siemens Healthcare Business Overview

11.11.3 Siemens Healthcare Infectious Diseases In Vitro Diagnostics Introduction

11.11.4 Siemens Healthcare Revenue in Infectious Diseases In Vitro Diagnostics Business (2019-2024)

11.11.5 Siemens Healthcare Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Abbott

Alere Inc

Quidel

F.Hoffmann-La Roche

Orasure Technologies

Cepheid Inc

Hologic Inc

Qiagen NV

Bio Rad Laboratories

Siemens Healthcare

List of Tables

Table 1. Global Infectious Diseases In Vitro Diagnostics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of MRSA

Table 3. Key Players of Streptococcus

Table 4. Key Players of TB and Drug-resistant TB

Table 5. Key Players of Gastro-intestinal Panel Testing

Table 6. Key Players of HIV

Table 7. Key Players of Hepatitis C

Table 8. Key Players of Others

Table 9. Global Infectious Diseases In Vitro Diagnostics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 10. Global Infectious Diseases In Vitro Diagnostics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 11. Global Infectious Diseases In Vitro Diagnostics Market Size by Region (2019-2024) & (US$ Million)

Table 12. Global Infectious Diseases In Vitro Diagnostics Market Share by Region (2019-2024)

Table 13. Global Infectious Diseases In Vitro Diagnostics Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 14. Global Infectious Diseases In Vitro Diagnostics Market Share by Region (2025-2030)

Table 15. Infectious Diseases In Vitro Diagnostics Market Trends

Table 16. Infectious Diseases In Vitro Diagnostics Market Drivers

Table 17. Infectious Diseases In Vitro Diagnostics Market Challenges

Table 18. Infectious Diseases In Vitro Diagnostics Market Restraints

Table 19. Global Infectious Diseases In Vitro Diagnostics Revenue by Players (2019-2024) & (US$ Million)

Table 20. Global Infectious Diseases In Vitro Diagnostics Market Share by Players (2019-2024)

Table 21. Global Top Infectious Diseases In Vitro Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Diseases In Vitro Diagnostics as of 2023)

Table 22. Ranking of Global Top Infectious Diseases In Vitro Diagnostics Companies by Revenue (US$ Million) in 2023

Table 23. Global 5 Largest Players Market Share by Infectious Diseases In Vitro Diagnostics Revenue (CR5 and HHI) & (2019-2024)

Table 24. Key Players Headquarters and Area Served

Table 25. Key Players Infectious Diseases In Vitro Diagnostics Product Solution and Service

Table 26. Date of Enter into Infectious Diseases In Vitro Diagnostics Market

Table 27. Mergers & Acquisitions, Expansion Plans

Table 28. Global Infectious Diseases In Vitro Diagnostics Market Size by Type (2019-2024) & (US$ Million)

Table 29. Global Infectious Diseases In Vitro Diagnostics Revenue Market Share by Type (2019-2024)

Table 30. Global Infectious Diseases In Vitro Diagnostics Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 31. Global Infectious Diseases In Vitro Diagnostics Revenue Market Share by Type (2025-2030)

Table 32. Global Infectious Diseases In Vitro Diagnostics Market Size by Application (2019-2024) & (US$ Million)

Table 33. Global Infectious Diseases In Vitro Diagnostics Revenue Market Share by Application (2019-2024)

Table 34. Global Infectious Diseases In Vitro Diagnostics Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 35. Global Infectious Diseases In Vitro Diagnostics Revenue Market Share by Application (2025-2030)

Table 36. North America Infectious Diseases In Vitro Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 37. North America Infectious Diseases In Vitro Diagnostics Market Size by Country (2019-2024) & (US$ Million)

Table 38. North America Infectious Diseases In Vitro Diagnostics Market Size by Country (2025-2030) & (US$ Million)

Table 39. Europe Infectious Diseases In Vitro Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 40. Europe Infectious Diseases In Vitro Diagnostics Market Size by Country (2019-2024) & (US$ Million)

Table 41. Europe Infectious Diseases In Vitro Diagnostics Market Size by Country (2025-2030) & (US$ Million)

Table 42. Asia-Pacific Infectious Diseases In Vitro Diagnostics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 43. Asia-Pacific Infectious Diseases In Vitro Diagnostics Market Size by Region (2019-2024) & (US$ Million)

Table 44. Asia-Pacific Infectious Diseases In Vitro Diagnostics Market Size by Region (2025-2030) & (US$ Million)

Table 45. Latin America Infectious Diseases In Vitro Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 46. Latin America Infectious Diseases In Vitro Diagnostics Market Size by Country (2019-2024) & (US$ Million)

Table 47. Latin America Infectious Diseases In Vitro Diagnostics Market Size by Country (2025-2030) & (US$ Million)

Table 48. Middle East & Africa Infectious Diseases In Vitro Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 49. Middle East & Africa Infectious Diseases In Vitro Diagnostics Market Size by Country (2019-2024) & (US$ Million)

Table 50. Middle East & Africa Infectious Diseases In Vitro Diagnostics Market Size by Country (2025-2030) & (US$ Million)

Table 51. BD Company Detail

Table 52. BD Business Overview

Table 53. BD Infectious Diseases In Vitro Diagnostics Product

Table 54. BD Revenue in Infectious Diseases In Vitro Diagnostics Business (2019-2024) & (US$ Million)

Table 55. BD Recent Development

Table 56. Abbott Company Detail

Table 57. Abbott Business Overview

Table 58. Abbott Infectious Diseases In Vitro Diagnostics Product

Table 59. Abbott Revenue in Infectious Diseases In Vitro Diagnostics Business (2019-2024) & (US$ Million)

Table 60. Abbott Recent Development

Table 61. Alere Company Detail

Table 62. Alere Business Overview

Table 63. Alere Infectious Diseases In Vitro Diagnostics Product

Table 64. Alere Revenue in Infectious Diseases In Vitro Diagnostics Business (2019-2024) & (US$ Million)

Table 65. Alere Recent Development

Table 66. Quidel Company Detail

Table 67. Quidel Business Overview

Table 68. Quidel Infectious Diseases In Vitro Diagnostics Product

Table 69. Quidel Revenue in Infectious Diseases In Vitro Diagnostics Business (2019-2024) & (US$ Million)

Table 70. Quidel Recent Development

Table 71. F. Hoffmann-La Roche Company Detail

Table 72. F. Hoffmann-La Roche Business Overview

Table 73. F. Hoffmann-La Roche Infectious Diseases In Vitro Diagnostics Product

Table 74. F. Hoffmann-La Roche Revenue in Infectious Diseases In Vitro Diagnostics Business (2019-2024) & (US$ Million)

Table 75. F. Hoffmann-La Roche Recent Development

Table 76. Orasure Technologies Company Detail

Table 77. Orasure Technologies Business Overview

Table 78. Orasure Technologies Infectious Diseases In Vitro Diagnostics Product

Table 79. Orasure Technologies Revenue in Infectious Diseases In Vitro Diagnostics Business (2019-2024) & (US$ Million)

Table 80. Orasure Technologies Recent Development

Table 81. Cepheid Company Detail

Table 82. Cepheid Business Overview

Table 83. Cepheid Infectious Diseases In Vitro Diagnostics Product

Table 84. Cepheid Revenue in Infectious Diseases In Vitro Diagnostics Business (2019-2024) & (US$ Million)

Table 85. Cepheid Recent Development

Table 86. Hologic Company Detail

Table 87. Hologic Business Overview

Table 88. Hologic Infectious Diseases In Vitro Diagnostics Product

Table 89. Hologic Revenue in Infectious Diseases In Vitro Diagnostics Business (2019-2024) & (US$ Million)

Table 90. Hologic Recent Development

Table 91. Qiagen Company Detail

Table 92. Qiagen Business Overview

Table 93. Qiagen Infectious Diseases In Vitro Diagnostics Product

Table 94. Qiagen Revenue in Infectious Diseases In Vitro Diagnostics Business (2019-2024) & (US$ Million)

Table 95. Qiagen Recent Development

Table 96. Bio-Rad Laboratories Company Detail

Table 97. Bio-Rad Laboratories Business Overview

Table 98. Bio-Rad Laboratories Infectious Diseases In Vitro Diagnostics Product

Table 99. Bio-Rad Laboratories Revenue in Infectious Diseases In Vitro Diagnostics Business (2019-2024) & (US$ Million)

Table 100. Bio-Rad Laboratories Recent Development

Table 101. Siemens Healthcare Company Detail

Table 102. Siemens Healthcare Business Overview

Table 103. Siemens Healthcare Infectious Diseases In Vitro Diagnostics Product

Table 104. Siemens Healthcare Revenue in Infectious Diseases In Vitro Diagnostics Business (2019-2024) & (US$ Million)

Table 105. Siemens Healthcare Recent Development

Table 106. Research Programs/Design for This Report

Table 107. Key Data Information from Secondary Sources

Table 108. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Infectious Diseases In Vitro Diagnostics Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Infectious Diseases In Vitro Diagnostics Market Share by Type: 2023 VS 2030

Figure 3. MRSA Features

Figure 4. Streptococcus Features

Figure 5. TB and Drug-resistant TB Features

Figure 6. Gastro-intestinal Panel Testing Features

Figure 7. HIV Features

Figure 8. Hepatitis C Features

Figure 9. Others Features

Figure 10. Global Infectious Diseases In Vitro Diagnostics Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 11. Global Infectious Diseases In Vitro Diagnostics Market Share by Application: 2023 VS 2030

Figure 12. Immunochemistry Case Studies

Figure 13. Molecular Diagnostics Case Studies

Figure 14. Microbiology Case Studies

Figure 15. Others Case Studies

Figure 16. Infectious Diseases In Vitro Diagnostics Report Years Considered

Figure 17. Global Infectious Diseases In Vitro Diagnostics Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 18. Global Infectious Diseases In Vitro Diagnostics Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 19. Global Infectious Diseases In Vitro Diagnostics Market Share by Region: 2023 VS 2030

Figure 20. Global Infectious Diseases In Vitro Diagnostics Market Share by Players in 2023

Figure 21. Global Top Infectious Diseases In Vitro Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Diseases In Vitro Diagnostics as of 2023)

Figure 22. The Top 10 and 5 Players Market Share by Infectious Diseases In Vitro Diagnostics Revenue in 2023

Figure 23. North America Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. North America Infectious Diseases In Vitro Diagnostics Market Share by Country (2019-2030)

Figure 25. United States Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Canada Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Europe Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Europe Infectious Diseases In Vitro Diagnostics Market Share by Country (2019-2030)

Figure 29. Germany Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. France Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. U.K. Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Italy Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Russia Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Nordic Countries Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Asia-Pacific Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Asia-Pacific Infectious Diseases In Vitro Diagnostics Market Share by Region (2019-2030)

Figure 37. China Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Japan Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. South Korea Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Southeast Asia Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. India Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Australia Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Latin America Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Latin America Infectious Diseases In Vitro Diagnostics Market Share by Country (2019-2030)

Figure 45. Mexico Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Brazil Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Middle East & Africa Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Middle East & Africa Infectious Diseases In Vitro Diagnostics Market Share by Country (2019-2030)

Figure 49. Turkey Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 50. Saudi Arabia Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 51. BD Revenue Growth Rate in Infectious Diseases In Vitro Diagnostics Business (2019-2024)

Figure 52. Abbott Revenue Growth Rate in Infectious Diseases In Vitro Diagnostics Business (2019-2024)

Figure 53. Alere Revenue Growth Rate in Infectious Diseases In Vitro Diagnostics Business (2019-2024)

Figure 54. Quidel Revenue Growth Rate in Infectious Diseases In Vitro Diagnostics Business (2019-2024)

Figure 55. F. Hoffmann-La Roche Revenue Growth Rate in Infectious Diseases In Vitro Diagnostics Business (2019-2024)

Figure 56. Orasure Technologies Revenue Growth Rate in Infectious Diseases In Vitro Diagnostics Business (2019-2024)

Figure 57. Cepheid Revenue Growth Rate in Infectious Diseases In Vitro Diagnostics Business (2019-2024)

Figure 58. Hologic Revenue Growth Rate in Infectious Diseases In Vitro Diagnostics Business (2019-2024)

Figure 59. Qiagen Revenue Growth Rate in Infectious Diseases In Vitro Diagnostics Business (2019-2024)

Figure 60. Bio-Rad Laboratories Revenue Growth Rate in Infectious Diseases In Vitro Diagnostics Business (2019-2024)

Figure 61. Siemens Healthcare Revenue Growth Rate in Infectious Diseases In Vitro Diagnostics Business (2019-2024)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions